Project Grant R15HD108720
Award Date
9/8/22
Completion Date
8/31/25
Dollars Obligated
$876K
Federal Agency
National Institute of Child Health and Human Development
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Denton, TX 76203, USA
Similar Awards
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $161,500 to support research aimed at understanding the molecular mechanisms underlying heterotaxy, a severe form of congenital heart disease (CHD) affecting left-right asymmetry of internal organs. The award, granted to the Rector & Visitors of the University of Virginia, will establish basic...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), is focused on interpreting the impact of genetic variants, including both coding and non-coding variants, on congenital heart disease (CHD). The $802,762 award to The University of Texas Southwestern Medical Center will be used to: 1) Define the transcription factors and gene regulatory networks underlying human cardiac development; 2)...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $2,258,439 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to Oregon Health & Science University (OHSU) to investigate how cardiomyocyte growth is regulated in a fetal ovine model of reduced left ventricular filling. The research aims to better understand the physical and hormonal factors that regulate cardiomyocyte growth, maturation, and survival before birth in fetuses with impaired left heart inflow, which...
This Project Grant award, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), supports a comprehensive research project to investigate the development of diverse cardiac cell types and their organization into heart structures. The $1,451,467 award, with a project period from July 1, 2024 to June 30, 2028, will be performed by the University of California, San Diego (UCSD). The research aims to identify and examine...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $605,275 to The Regents of the University of California, San Francisco (UCSF) to conduct research on the developmental mechanisms underlying left-right patterning of the interventricular septum and the etiology of ventricular septal defects (VSDs), which are common congenital heart defects. The key objectives are to delineate how...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will fund the development of a 3D bioprinted heart tube model to study how aberrant biomechanical forces impede cardiac proliferation in Hypoplastic Left Heart Syndrome (HLHS). The total funding amount is $148,548, awarded to the Research Institute at Nationwide Children's Hospital (RINCH), a prominent non-profit research organization. The project...
This federal Project Grant award of $817,424 from the National Heart, Lung, and Blood Institute (NHLBI)'s Cardiovascular Diseases Research program (CFDA 93.837) will support research at Yale University focused on understanding the electrophysiological properties of embryos and their role in congenital heart disease (CHD). The overarching goal is to investigate how ion channels define electrical membrane potential and regulate voltage-gated calcium channels in early embryonic cells, as this...
This federal Project Grant award for $675,606 from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports research to investigate the mechanisms of signaling interaction between cardiomyocytes in the myocardium and endocardial cells in the endocardium during heart development. The research aims to determine the ultrastructure and function of signaling bridges, a novel microstructure that facilitates communication between these cell types, and...
This $544,924 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to investigate the role of the YAP/TAZ signaling pathway in the development of congenital diaphragmatic hernia (CDH)-related lung hypoplasia. The project, led by researchers at The Johns Hopkins University, will utilize mouse models, human lung organoids, and micro-mechanical compression devices to examine how mechanical...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $506,984 to the University of Pittsburgh to conduct research on the role of the LRP1 gene in the development of congenital heart disease (CHD). The key objectives are to: Investigate the deployment and migration of cardiac neural crest cells (CNCCs) and how LRP1 deficiency in CNCCs can lead to outflow tract and atrioventricular valve...